HRTS vs. ARKG ETF Comparison
Comparison of Tema Cardiovascular and Metabolic ETF (HRTS) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
HRTS
Tema Cardiovascular and Metabolic ETF
HRTS Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$33.20
Average Daily Volume
14,638
36
ARKG
ARK Genomic Revolution Multi-Sector ETF
ARKG Description
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.Grade (RS Rating)
Last Trade
$24.00
Average Daily Volume
1,832,233
34
Performance
Period | HRTS | ARKG |
---|---|---|
30 Days | -0.75% | -3.38% |
60 Days | -6.06% | -9.06% |
90 Days | -1.75% | -2.52% |
12 Months | -1.36% |
HRTS Overweight 31 Positions Relative to ARKG
Symbol | Grade | Weight | |
---|---|---|---|
LLY | F | 5.48% | |
ALNY | C | 5.47% | |
CRNX | B | 3.79% | |
BBIO | D | 3.62% | |
CYTK | F | 3.25% | |
MDT | B | 2.9% | |
MREO | D | 2.68% | |
MASI | A | 2.52% | |
BSX | C | 2.28% | |
RARE | D | 2.22% | |
MIRM | B | 2.08% | |
RCKT | F | 2.07% | |
ASND | F | 2.06% | |
MLYS | B | 2.05% | |
PODD | A | 2.03% | |
DXCM | C | 1.99% | |
EW | D | 1.97% | |
KROS | A | 1.96% | |
ARWR | F | 1.58% | |
NVS | D | 1.33% | |
AKRO | A | 1.19% | |
WST | B | 1.17% | |
SLN | F | 1.13% | |
VKTX | A | 1.07% | |
EWTX | B | 0.99% | |
MDGL | A | 0.95% | |
NARI | A | 0.84% | |
TERN | D | 0.72% | |
VERV | C | 0.64% | |
TNYA | F | 0.38% | |
RANI | F | 0.32% |
HRTS Underweight 29 Positions Relative to ARKG
Symbol | Grade | Weight | |
---|---|---|---|
TWST | F | -8.58% | |
CRSP | C | -7.19% | |
RXRX | F | -7.13% | |
CDNA | D | -5.09% | |
VCYT | A | -4.56% | |
ADPT | A | -4.37% | |
NRIX | B | -4.29% | |
NTRA | B | -3.75% | |
TXG | F | -3.63% | |
SDGR | F | -3.51% | |
BEAM | F | -3.46% | |
ARCT | F | -3.22% | |
PSNL | C | -2.91% | |
GH | D | -2.64% | |
ABSI | D | -2.43% | |
VEEV | B | -2.13% | |
PACB | C | -2.11% | |
ACCD | F | -1.42% | |
BFLY | A | -1.32% | |
EXAS | A | -1.26% | |
INCY | A | -1.25% | |
CERS | F | -1.12% | |
MRNA | F | -1.08% | |
CMPS | F | -1.0% | |
PRME | C | -0.92% | |
MASS | F | -0.86% | |
QSI | F | -0.73% | |
RPTX | C | -0.72% | |
ILMN | A | -0.26% |
HRTS: Top Represented Industries & Keywords
ARKG: Top Represented Industries & Keywords